We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Early Gene Therapy Data Promising for Sickle Cell Anemia

News   Dec 04, 2018 | Original story from Cincinnati Children's Hospital Medical Center

 
Gene Therapy is Reversing Sickle Cell Anemia Symptoms in Preclinical Trials

Technicians work in the ISO-certified cleanroom laboratory at Cincinnati Children’s where gene-correction therapies are tested and produced for clinical trials like the one for sickle cell anemia presented by Punam Malik MD, at this year’s annual meeting of the American Society of Hematology in San Diego. Image credit: Cincinnati Children's Hospital

 
 
 

RELATED ARTICLES

Hat Could One Day Reverse Baldness – And It's Cheap Too!

News

Few things on earth strike fear into the hearts of men more profoundly than hair loss. But reversing baldness could someday be as easy as wearing a hat, thanks to a noninvasive, low-cost hair-growth-stimulating technology developed by engineers at the University of Wisconsin–Madison.

READ MORE

A Cure for the Common Cold?

News

Disabling a single, apparently noncritical protein in cells may foil replication of the viruses that cause half of all common colds, polio and other diseases.

READ MORE

Evidence Reinforcing Approval of New Cancer Drugs Raises Questions

News

Around half of trials that supported new cancer drug approvals in Europe between 2014 and 2016 were judged to be at high risk of bias, according to a new study.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE